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Summary
Synaptic transmission between neurones intrinsic to the wall of the intestine involves multiple neurotransmitters. This study aimed to identify neurotransmitters responsible for non-cholinergic excitatory synaptic transmission in the submucous plexus of the guinea pig ileum. Intracellular recordings were made from secretomotor and vasodilator neurones. A single electrical stimulus to a fibre tract evoked excitatory post synaptic potentials (EPSPs) with three different time courses -fast, slow, and an EPSP with an intermediate time course (latency 96ms, duration 1.2s). In all neurones, blocking nicotinic receptors reduced fast EPSPs, but they were abolished in only 57 of 78 neurones. Fast EPSPs were also reduced by P2 receptor blockade (5 of 27 neurones) 
Introduction
ATP acting via P2X receptors has been established as a neurotransmitter in several parts of the central nervous system (Robertson et al., 2001) . However, it is only in the enteric nervous system (ENS) that a function for fast excitatory synaptic potentials (EPSPs) mediated via P2X receptors has been shown. They mediate transmission between interneurones and motor neurones in descending inhibitory reflexes of guineapig ileum (Bian et al., 2000) . Their specific role elsewhere within the ENS (Spencer et al., 2000; Monro et al., 2002) has not been established although ATP may play a role in regulating secretomotor neurones via slow EPSPs mediated by P2Y 1 receptors (Hu et al., 2003) (for reviews see: Galligan, 2002; Bertrand, 2003) .
The enteric nervous system is composed of two ganglionated plexes: the myenteric plexus that controls motility and the submucous plexus that controls secretion/absorption. Submucous neurones in the guinea-pig ileum display up to six distinct synaptic potentials in response to electrical stimulation of fibre tracts. These are fast EPSPs, two types of slow EPSP, two types of inhibitory synaptic potential (IPSP) and an EPSP with a time course longer than that of a fast EPSP, but shorter than a slow EPSP (Hirst & McKirdy, 1975; Surprenant, 1984; Bornstein et al., 1986; Mihara et al., 1987; . This last potential has been termed an intermediate EPSP and is not as well characterized as the other synaptic potentials (Bornstein et al., 1986) .
Functionally there are four classes of neurone in the submucous plexus: cholinergic secretomotor neurones (containing neuropeptide Y), non-cholinergic secretomotor neurones (containing vasoactive intestinal peptide, VIP), cholinergic vasodilator neurones, and intrinsic sensory neurones. Fast EPSPs are common in secretomotor and vasodilator neurones, which together comprise around 85% of the total number of neurones (Bornstein et al., 1986) . The remaining 15% are intrinsic sensory neurones and rarely display fast EPSPs . Slow EPSPs evoked by a train of stimuli are seen in all classes of neurone, but those evoked by a single stimulus are confined to the non-cholinergic secretomotor neurones (Bornstein et al., 1986) . IPSPs are also confined to the non-cholinergic secretomotor class (Bornstein et al., 1986; Evans et al., 1994) .
Fast EPSPs in the myenteric plexus are mediated by acetylcholine (ACh), ATP and, to a lesser extent, 5-HT (Galligan & Bertrand, 1994; LePard et al., 1997; LePard & Galligan, 1999; Zhou & Galligan, 1999) . Studies of submucosal fast EPSPs have, however, concluded that they are mediated exclusively by ACh acting at nicotinic receptors (Hirst & McKirdy, 1975; Moore & Vanner, 1998 . Nonetheless, submucous neurones express P2X 2 (Castelucci et al., 2002) and P2X 3 (Poole et al., 2002; Van Nassauw et al., 2002) receptors and there is evidence that ATP is released from several classes of presynaptic neurone (Hu et al., 2003) . Myenteric neurones immunoreactive for 5-HT project to the submucous plexus and submucous neurones respond to both 5-HT and ATP with fast ligand-gated depolarizations that are blocked by 5-HT 3 (Surprenant & Crist, 1988) 
Methods

Tissue preparation
Guinea pigs of either sex in the weight range 180-350 g were stunned and killed by a blow to the back of the head followed by severing of the carotid arteries and spinal cord, in accordance with the guidelines of the University of Melbourne Animal Experimentation Ethics Committee. The abdominal cavity was opened and a 3 cm segment of ileum was Oxygenated physiological salt solution was pre-warmed to 34 -36° C and superfused at a rate of 2 -4 mL/min. The preparation was allowed to equilibrate for 1 hr before intracellular recordings began.
Electrophysiology
Submucosal ganglia were visualized at 300× using an inverted microscope (IMT-2 or IX-70, Olympus, Tokyo, Japan) with either Nomarski or Hoffman differential interference contrast optics. Neurones were impaled with glass microelectrodes containing 1M KCl and 2% biocytin (w/v) (tip resistance 100 -230 MΩ) using conventional techniques and characterized electrophysiologically as either S or AH type (Hirst et al., 1974) . Neurones that could be classified as AH neurones based on their action potential shape or long after-hyperpolarizing potential were excluded from this study, even though submucosal AH neurones do exhibit some fast EPSPs . Voltage recordings were made using an Axoprobe 1A or Axoclamp 2A (bridge mode) amplifier, digitized at 5 -20 kHz (Digidata 1200B) and recorded on a personal computer using Axoscope 9 (all from Axon Instruments, Foster City, CA, USA). Impalement times ranged from 30 mins to over 4 hrs with neuronal characterization starting at least 10 minutes after impalement.
Synaptic potentials were evoked by electrical stimulation of interganglionic fibre tracts located further than one neighbouring ganglion away from the impaled neurone (up to 1.2 mm away) using a 25 µ m insulated tungsten monopolar stimulating electrode. Fast EPSPs, intermediate EPSPs and single stimulus slow EPSPs were evoked using a single pulse (Bornstein et al., 1986) , typically 0.08 mA (0.6 to 1.2 mA) and 0.5 ms (up to 2.0 ms) duration (Master-8 stimulator, ISO-Flex stimulus isolation unit; both from A.M.P.I., Jerusalem, Israel). A train of 5 pulses at 20 Hz or 3 pulses at 30 Hz was used to evoke IPSPs and/or multi-stimuli slow EPSPs (Surprenant, 1984; Bornstein et al., 1986) . Fast and intermediate EPSPs were recorded at membrane potentials of -70 to -90 mV to maximize their amplitude and to reduce the likelihood of action potential initiation. Slow EPSPs and IPSPs were recorded at, or close to, resting membrane potential (about -50 mV) as they are predominately due to changes in potassium conductance (Surprenant, 1984) .
For each neurone, the current that evoked the smallest distinct fast EPSP was determined (threshold stimulus) and this was increased until a fast EPSP of maximal amplitude was evoked (maximal stimulus). The current was then increased to 20 to 30% beyond maximal (supramaximal stimulus) and used for the remainder of the experiment.
One of the consequences of using a supramaximal stimulus was that fast EPSPs were likely to be the product of several presynaptic fibres (Bornstein et al., 1987) , but this stimulus regime was required to ensure that variations in the amplitude of fast EPSPs were not simply due to changes in the number of presynaptic fibres activated. As the stimulating electrode was typically around 1 mm from the impaled neurone, the arrival of action potentials in the different terminals would be nearly simultaneous (within 1 -2 ms of each other). Thus, these fast EPSPs should still show relatively simple onset and decay kinetics.
Once the electrophysiological and pharmacological characterizations were completed cells were filled with biocytin and the position of the neurone within the ganglion, and the ganglion within the preparation, was noted for later identification following immunohistochemical processing.
Immunohistochemistry
Preparations were processed immunohistochemically to reveal the presence of VIP and biocytin. Briefly, preparations were fixed in Zamboni's fixative (2% formaldehyde plus 0.2% picric acid in 0.1 M phosphate buffer, pH 7.0) at 4° C for between 1 and 24 hrs, cleared of fixative and permeabilized using dimethyl sulfoxide (3 × 10 min washes), and then washed in phosphate buffered saline (3 × 10 min washes). The preparations were 
Drugs and Solutions
Receptor antagonists were prepared as stock solutions (generally 1000-fold concentration) in distilled water and kept at 4° C. They included hexamethonium, idazoxan, mecamylamine, pyridoxal phosphate-6-azophenyl-2',4'-disulphonic acid (PPADS), suramin (all from Sigma-Aldrich Fine Chemicals, Sydney, Australia), dihydro-β-erythroidine (RBI, Natick, MA, USA), granisetron (a kind gift from SmithKline Beecham, Australia) and MRS 2179 (Tocris, Australian Laboratory Services, Sydney, Australia). The voltage-gated sodium channel blocker, tetrodotoxin (TTX; Alomone Labs, Jerusalem, Israel), was also used. Drugs were diluted to the final concentration in physiological salt solution before addition to the organ bath. They were allowed to equilibrate for 5 mins before synaptic potentials were evoked in their presence and were washed out for 20 -30 mins before recovery of responses were sought.
The physiological salt solution was used as the basis for the low Ca 2+ (0.25 mM) high Mg 2+ (12 mM) solution used to prevent calcium-dependent transmitter release, and for the isethionate (118 mM) and choline (50 mM) substitutions for chloride (118 mM) and sodium (50mM), respectively (sodium isethionate and choline chloride, both from SigmaAldrich Fine Chemicals, Sydney, Australia). These solutions were superfused for approximately 3 mins before testing for synaptic potentials and approximately 10 mins was allowed afterwards for the physiological salt solution to establish normal ion concentrations again.
Choline chloride (1 mM) was prepared in HEPES (10 mM)-buffered saline (120 mM NaCl, pH 7.2) on the day of use. It was applied to the cell body by pressure ejection to compare data for significant differences with a P value of <0.05 taken as the cut-off for significance. All t-tests were one-tailed and paired unless noted.
Results
A total of 134 S-type neurones from 129 preparations were characterized electrophysiologically for basic cellular and synaptic properties. The average initial resting membrane potential measured was -54 ± 0.7 mV (from -40 to -70 mV; n = 118) and input resistance 237 ± 13 MΩ (36 to 898 MΩ). Action potential (AP) shape was observed by applying a 5 ms depolarizing pulse through the recording electrode to evoke a single AP; the duration of the falling phase of the AP at half amplitude (the half width) was 0.81 ± 0.03 (0.45 to 2 ms; n = 83). Failure to fire an AP occurred in 16 neurones despite the presence of a fast EPSP. A prominent shoulder was observed on
repolarization from a hyperpolarizing current pulse (due to an A-type potassium-like current, I A -like) in 92 neurones (69%) and a sag during the hyperpolarizing pulse (due to a hyperpolarization-activated cation-like current, I H -like) was seen in 29 neurones (22%;
for correlation with cell types see Table 1 ).
A single pulse stimulus (0.5 to 2 ms, 0.6 to 1. 
Fast EPSPs
Fast EPSPs from 78 neurones were examined pharmacologically. The mean amplitude of the fast EPSPs was 23 ± 1 mV (median 23 mV) and duration at half amplitude was 24 ± 1 ms (range 9 to 47 ms, median 24 ms, n = 60). Many fast EPSPs also had distinct peaks or bumps occurring, some with consistent latencies, after the initial peak on the falling phase of the potential. One interpretation is that some of the individual fast
EPSPs that make up the response are arriving through multiple synapses.
Fast EPSPs could be blocked by the addition of tetrodotoxin (TTX; 300 nM; n = 2) to block voltage-gated sodium channels and, thus, prevent axonal propagation of action potentials, or by substituting the physiological salt solution for one containing a lower concentration of Ca 2+ (0.25 mM) and a higher concentration of Mg 2+ (12 mM) to block calcium-dependent transmitter release (n = 14).
Effect of nicotinic receptor antagonists
Fast EPSPs were abolished in 57 of 73 neurones (78%) by a nicotinic receptor antagonist (1 mV remaining from 21 mV; Figure 2A ). In the remaining 16 neurones (22%), the fast EPSPs were reduced from 32 mV to 11 mV (34% of control), thus, revealing a non-nicotinic component.
The effects of the main nicotinic receptor antagonist used, hexamethonium, were concentration dependent, as in some experiments 100 µM hexamethonium left a residual fast EPSP that was blocked by increasing the concentration to 300 µM. The blockade was specific because two other nicotinic receptor antagonists, mecamylamine
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(30 µM, n = 5) and dihydro-β-erythroidine (30 µM, n = 2), were as effective as the higher concentration of hexamethonium.
Effect of P2X receptor antagonists
P2 receptor antagonists were tested on 27 neurones, 7 of which had fast EPSPs with a non-nicotinic component. In 5 of the 27 neurones, P2 receptor blockade (either with or without additional nicotinic receptor blockade) reduced the fast EPSP amplitude. In 2 neurones, addition of PPADS (pyridoxal phosphate-6-azophenyl-2',4'-disulphonic acid, 10 or 30 µM) to the bath reduced the fast EPSP amplitude from 21 mV to 14 mV (67% of control); suramin (100 µM) was tested in 1 of these neurones and also attenuated the fast EPSP. In 3 neurones, hexamethonium left a 15 mV residual fast EPSP (39% of control) and addition of PPADS and hexamethonium together abolished this ( Figure 2B ).
In 7 of the 27 neurones, PPADS caused an increase in the amplitude of the fast EPSP (from 31 mV to 38 mV; 123% of control); this increase was not reversed following wash out. In 5 of the 7 neurones, hexamethonium abolished the fast EPSP. In another neurone, the fast EPSP was reduced by hexamethonium, increased by PPADS, but was abolished by the combination of PPADS and hexamethonium. In 2 neurones both PPADS and suramin were tested; PPADS acted to increase the fast EPSP amplitude, whereas suramin had no effect or decreased it.
In 15 of the 27 neurones, P2 receptor antagonists had no effect on fast EPSP amplitude.
It was, however, noted that PPADS narrowed the width (at half amplitude) of the compound fast EPSP from 21 ms to 18 ms (86%, n = 10, P<0.05). This reduction in width was associated with a disappearance of the later distinct peaks on the falling Page 13 phase of the potential. We interpret this to mean that PPADS had blocked multi-synaptic fast EPSPs and was, thus, having an affect at an upstream synapse.
Effect of 5-HT 3 receptor antagonist
The 5-HT 3 receptor antagonist granisetron was tested in 20 neurones. In 3 of the 20 neurones, granisetron (300nM or 1 µM) caused a clear decrease in the fast EPSP amplitude from 23 mV to 12 mV (52% of control; Figure 3C ); 2 with a hexamethoniumresistant fast EPSP and 1 that was untested with nicotinic blockade.
In 17 of 20 neurones, granisetron had no effect. In 13 neurones, there was a nicotinic only fast EPSP while in 4 neurones there was a hexamethonium-resistant component to the fast EPSP. In 5 neurones where granisetron did not alter the amplitude of the fast EPSP it did cause a non-significant decrease in duration of the average fast EPSP response. This suggests that again, multi-synaptic fast EPSPs may have been blocked by granisetron at an upstream synapse.
Intermediate EPSP Characteristics of the intermediate EPSP
An EPSP with a duration of 500 to 1500 ms has previously been described in the submucous plexus by Bornstein et al. (1986) . As it had a time course longer than a fast EPSP (10s of milliseconds), but shorter than a slow EPSP (10s of seconds), it was (10 µM; Figure 4B ) attenuated or abolished (control 6 mV to 1 mV) the intermediate EPSP in all neurones tested (n = 12, 4 and 5, respectively). Addition of granisetron (300 nM or 1 µM) to the bath had no effect on the intermediate EPSP (control 2 mV, granisetron 2 mV, n = 9).
Pharmacology of the preceding fast EPSP
The electrically evoked intermediate EPSP was always preceded by a fast EPSP (e.g., Figure 3 ). This fast EPSP was blocked by hexamethonium in 24 neurones ( Figure 3C ), or was sensitive to both hexamethonium and PPADS in 4 neurones (P2 receptor
antagonists not tested in 6 neurones where there was a non-nicotinic component;
nicotinic receptor antagonists not tested in 4 neurones); there was no effect of granisetron (13 tested). All neurones with a purinergic component to the fast EPSP had an intermediate EPSP. We substituted 50 mM choline chloride for 50 mM of the sodium chloride in the bathing solution, and under these conditions somatic depolarization could still evoke an AP suggesting synaptic transmission should be intact. Despite this, synaptic transmission still appeared to be depressed. It was noted that as the choline chloride entered the bath the neurones were strongly depolarized. To assess the effects of choline more directly, choline chloride at 1mM (in HEPES buffered saline) was applied by pressure ejection onto the cell bodies. In 4 of 4 neurones tested choline caused a fast depolarization that was reduced or abolished by nicotinic receptor blockade (hexamethonium 300 µM)
Ionic basis of the intermediate EPSP
suggesting choline is a potent agonist at the subtype of nicotinic receptor present on submucosal neurones (see Discussion; Seddik et al., 2003) .
Slow EPSP
A single pulse stimulus evoked a slow EPSP, as previously reported by Surprenant et al (1984) and Bornstein et al (1986) , in 13 of 134 neurones (10%). This slow EPSP had an average amplitude of 7 ± 1 mV and duration of 14 ± 1 s. Addition of PPADS (10 or 30 µM) to the bath resulted in a large reduction in the amplitude of the single pulse slow EPSP from 7 mV to 2 mV in 3 neurones ( Figure 6A ). The selective P2Y 1 antagonist MRS 2179 (10 µM) also greatly reduced the amplitude of the single pulse slow EPSP from 5 mV to 1 mV in the 3 neurones tested ( Figure 6B ).
Correlation between the three excitatory synaptic potentials (fast, intermediate and slow)
was tested in 7 neurones with a single shock slow EPSP: 6 neurones had an intermediate EPSP, 5 had a fast EPSP that was blocked by hexamethonium, while 2 had a fast EPSP sensitive to PPADS.
Immunohistochemical Correlation
Of the 134 neurones characterized electrophysiologically, 39 were also characterized immunohistochemically. Table 1 summarises the basic electrophysiological properties of these neurones. Of the 39 neurones, 22 were immunoreactive for VIP. Single pulse slow EPSPs were seen in 3 of these neurones and 19 had intermediate EPSPs (Table 2) .
Pharmacological characterization of synaptic potentials was carried out in 33 of the 39 neurones (Table 3) , 17 of which were immunoreactive for VIP. Fast EPSPs were completely blocked by hexamethonium in 13 neurones and 4 were partially resistant to hexamethonium -2 being sensitive to PPADS and 2 not tested with PPADS.
Of the 17 neurones not immunoreactive for VIP, 2 had a single pulse slow EPSP and 10 had an intermediate EPSP (Table 2) . Fast EPSPs were completely blocked by hexamethonium in 5 neurones, 2 were partially resistant to hexamethonium but PPADS was not tested, and 2 were not tested with nicotinic receptor blockade but suramin increased the amplitude in 1 (Table 3) .
Of the 7 neurones not immunoreactive for VIP and lacking an intermediate EPSP, 6 had fast EPSPs blocked by hexamethonium and 1 was sensitive to hexamethonium but PPADS increased the amplitude (Table 3 ). The cells with a fast EPSP sensitive to granisetron were not processed immunohistochemically.
Discussion
This study has shown that ATP has a considerable role in excitatory synaptic transmission in the submucous plexus of the guinea-pig ileum as it mediates three 
Cholinergic fast EPSPs
Approximately half the neurones in the submucous plexus are immunoreactive for VIP, a marker for non-cholinergic secretomotor neurones. Submucosal neurones without VIP immunoreactivity contain the ACh synthesizing enzyme choline acetyltransferase (ChAT; Furness et al., 1984) and are therefore cholinergic. These cholinergic neurones can be functionally subdivided into secretomotor ) and vasodilator neurones (Brookes et al., 1991) . The AH/intrinsic sensory neurones excluded from the present study are also cholinergic Furness et al., 1998) . In the present study, all fast EPSPs were depressed by nicotinic receptor antagonists. Thus, the three classes of neurone studied, non-cholinergic and cholinergic secretomotor neurones and vasodilator neurones, all exhibit fast EPSPs mediated at least partly by ACh acting at nicotinic receptors. We found that in some secretomotor neurones of each class, the fast EPSP was abolished by nicotinic receptor blockade indicating that ACh is the only transmitter involved. These data are consistent with previous electrophysiological studies of synaptic inputs to submucous neurones that found that the predominant excitatory input is via nicotinic receptors (Hirst & McKirdy, 1975; Surprenant, 1984; Moore & Vanner, 2000; Reed & Vanner, 2001) . It is also consistent with studies of mucosal chloride secretion and vasodilatation, which have shown that all secretomotor neurones respond to nicotinic receptor agonists (Keast et al., 1985; Hendriks et al., 1989) and that nicotinic transmission is essential for reflex activation of vasodilator neurones (Vanner, 2000) .
Non-cholinergic fast EPSPs
In approximately 20% of neurones, nicotinic receptor blockade left a residual noncholinergic fast EPSP. This could be blocked by a P2 receptor antagonist or a 5-HT 3 receptor antagonist and hence was due the actions of synaptically released ATP or 5-HT. This is similar to transmission in the myenteric plexus, where both ATP and 5-HT mediate fast EPSPs (Galligan & Bertrand, 1994; Zhou & Galligan, 1999) .
P2X receptors have been identified on submucous neurones
electrophysiologically (Barajas-Lopez et al., 1998) and immunohistochemically with P2X 2 receptors confined to non-cholinergic secretomotor neurones (Castelucci et al., 2002) and P2X 3 receptors on cholinergic vasodilator neurones and some cholinergic secretomotor neurones (Poole et al., 2002; Van Nassauw et al., 2002) . The chloride secretion evoked by ATP in colonic mucosa (e.g., Cuthbert & Hickman, 1985; Cooke et al, 2004 ) may be through these P2X receptors (see below).
As in the myenteric plexus (Zhou & Galligan, 1999) , fast EPSPs mediated by 5-HT were confined to a subset of submucous neurones. They were not seen in neurones with purinergic EPSPs, whether fast, intermediate or slow. Studies of neurally mediated secretion show that cholinergic secretomotor neurones are preferentially activated via 5-HT 3 receptors, while non-cholinergic secretomotor neurones are preferentially activated via higher affinity 5-HT receptors (Hendriks et al., 1989; Johnson et al., 1994) . This suggests that 5-HT mediated fast EPSPs occur in the cholinergic secretomotor neurones and is consistent with the observation that these neurones lack P2X 2 receptors and P2X 3 receptors are rare.
The 5-HT containing terminals in submucous ganglia originate from descending interneurones in the myenteric plexus and so the fast EPSPs mediated by 5-HT must be evoked from these myenteric neurones. These interneurones have a role in descending excitatory motor pathways (Monro et al., 2002) suggesting that the 5-HT 3 mediated fast EPSPs may play a role in coordinating secretion with motility.
Intermediate EPSPs
Most submucous neurones, including virtually all non-cholinergic secretomotor neurones, exhibit an intermediate EPSP. They can be evoked by a single electrical pulse stimulus or can occur spontaneously and can initiate action potentials.
Intermediate EPSPs had a latency of around 90 ms and a duration ranging from 450 ms to 2.5 s, placing their time course between that of the fast EPSP and slow EPSP ( Figure   6C ). They were abolished by tetrodotoxin and by a low Ca 2+ , high Mg 2+ solution confirming they result from action potential evoked, calcium-dependent, transmitter release. Intermediate EPSPs have previously been identified in the cholinergic secretomotor neurones (those containing neuropeptide Y -NPY; Bornstein et al., 1986) but this is the first description in non-cholinergic secretomotor (VIP containing)
neurones. Intermediate EPSPs were seen in virtually all (86%) VIP-immunoreactive neurones and in some VIP-negative neurones. These latter neurones are likely to be the cholinergic secretomotor neurones. Nearly half of submucous neurones are VIPimmunoreactive and another 30% are NPY-immunoreactive (Furness et al., 1984) , so contribution of a cation conductance cannot, however, be excluded because substitution of choline for extracellular Na + did not produce definitive results. In fact, we found that choline was a potent agonist at nicotinic receptors on submucosal neurones, suggesting functional α7 subunits are likely to be on submucous neurones (Kirchgessner & Liu, 1998 receptors that and suggests they are of the P2Y 1 subtype.
Intermediate EPSPs were only seen in neurones with purely nicotinic fast EPSPs or mixed nicotinic/purinergic. Purinergic fast EPSPs were also confined to neurones with an intermediate EPSP, suggesting that cholinergic secretomotor neurones activated by 5-HT 3 receptors are not the ones that express P2X 3 receptors. This implies that different subclasses of cholinergic secretomotor neurones receive input from distinct neural pathways, one using ATP and the other 5-HT.
Spontaneously occurring intermediate EPSPs were mostly preceded by a fast
EPSP that was phase-locked ( Figure 4C ). This suggests that both EPSPs resulted from activation of the same presynaptic nerve terminal and, thus, that ACh and ATP may be co-released. Some spontaneously occurring intermediate EPSPs were seen without a preceding fast EPSP indicating that non-cholinergic neurones also release ATP that can mediate these synaptic potentials. It is not clear which neurones release ATP, but a study by Hu et al (2003) has shown that the ATP mediating slow EPSPs in submucous neurones (see below) may come from submucous neurones, myenteric neurones and even extrinsic sympathetic nerves.
Slow EPSPs
Two types of slow EPSP are seen in submucous neurones (Bornstein et al., 1986) . One is similar to that seen in myenteric neurones that is evoked by a train of stimuli and involves a decrease in potassium conductance. The other is usually evoked by a single stimulus in non-cholinergic secretomotor neurones and has been reported to involve a conductance increase (Hu et al., 2003) or decrease (Surprenant, 1984; Bornstein et al., 1986) . In the present study we found this second type of slow EPSP had very little change in conductance and was blocked by a selective P2Y 1 receptor antagonist, confirming a recent study by Hu et al (2003) . Therefore, this synaptic potential is also mediated by ATP, and we can conclude that ATP mediates three types of EPSP in the submucous plexus. Indeed, all three types were evoked by a single stimulus in some non-cholinergic secretomotor neurones in this study.
Potentiation of fast EPSPs
P2 receptor blockade increased the fast EPSP amplitude in several neurones that had purely cholinergic fast EPSPs. Post-synaptic interactions between nicotinic and P2X receptors have been reported in enteric neurones (Barajas-Lopez et al., 1998; Khakh et al., 2000) , but it seems more likely this is a presynaptic effect. Kamiji et al (1994) reported that presynaptic P2 receptors inhibit synaptic transmission in the myenteric plexus. Alternatively, inhibitory adenosine receptors might be involved (Barajas-Lopez et al., 1996) as PPADS blocks the break down of ATP to adenosine (Lambrecht, 1996) .
Regardless, this observation suggests that synaptically released ATP has inhibitory effects in addition to its post synaptic excitatory effects.
Functional significance
Non-cholinergic secretomotor neurones are the major sites of integration for neural regulation of mucosal electrolyte secretion . They receive cholinergic fast EPSPs and slow EPSPs from myenteric and submucous neurones, and
IPSPs from sympathetic neurones and myenteric neurones (Bornstein et al., 1987; Moore & Vanner, 1998 Reed & Vanner, 2001; Hu et al., 2003) . ATP evokes chloride secretion via activation of secretomotor neurones in rat colonic mucosa (Cuthbert & Hickman, 1985) , but whether P2X or the P2Y receptors mediate this is unknown. In guinea pig distal colon, P2Y 1 receptors appear to play a major role in mechanically evoked reflex secretion (Cooke et al, 2004) . We have shown 
